Provided by Tiger Trade Technology Pte. Ltd.

Sana Biotechnology, Inc.

3.91
+0.17004.55%
Post-market: 3.86-0.0500-1.28%19:54 EDT
Volume:2.93M
Turnover:11.55M
Market Cap:1.17B
PE:-5.12
High:4.10
Open:3.78
Low:3.74
Close:3.74
52wk High:6.55
52wk Low:2.61
Shares:299.00M
Float Shares:191.00M
Volume Ratio:0.91
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7636
EPS(LYR):-0.9642
ROE:-152.87%
ROA:-29.16%
PB:7.56
PE(LYR):-4.06

Loading ...

Press Release: Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates

Dow Jones
·
May 12

Is Sana Biotechnology’s (SANA) Options Spike Before Earnings Hinting at a Repriced Cell Therapy Story?

Simply Wall St.
·
May 11

Sana Biotechnology (SANA) Valuation Check As Conference Update And Partnerships Keep Investor Focus High

Simply Wall St.
·
May 10

Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference

GlobeNewswire
·
May 06

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data From in Vivo Car T SG293 at the American Society of Gene & Cell Therapy (Asgct) 2026 Annual Meeting

THOMSON REUTERS
·
Apr 28

Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting

GlobeNewswire
·
Apr 28

Sana Biotechnology Rebalances Board Classes With Director Shift

TIPRANKS
·
Apr 24

Sana Biotechnology announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 24

Sana Biotechnology Is Maintained at Outperform by Wedbush

Dow Jones
·
Apr 14

Wedbush Raises Price Target on Sana Biotechnology to $7 From $6, Keeps Outperform Rating

MT Newswires Live
·
Apr 14

Citigroup, JPMorgan And 3 Stocks To Watch Heading Into Tuesday

Benzinga Earnings
·
Apr 14

Sana Biotechnology Secures Strategic Equity Investment from Mayo

TIPRANKS
·
Apr 14

Sana Biotechnology announces SC451 strategic collaboration with Mayo Clinic

TIPRANKS
·
Apr 14

Sana Biotechnology Inc - Sells 7.5 Mln Shares to Mayo Clinic at $3.33 per Share for $25 Mln - SEC Filing

THOMSON REUTERS
·
Apr 14

Sana Biotechnology sells 7,507,507 shares to Mayo Clinic for USD 25 million

Reuters
·
Apr 14

Sana Biotechnology, Mayo Clinic form strategic collaboration on type 1 diabetes cell therapy SC451

Reuters
·
Apr 14

Sana Biotechnology files Form 3; EVP and Chief Scientific Officer Dhavalkumar Dhirajlal Patel reports 99,510 common shares owned directly

Reuters
·
Mar 28

BUZZ - US STOCKS ON THE MOVE-Kyivstar Group, Applied Materials, Tevogen Bio

Reuters
·
Mar 14

Durable HIP Technology Data De‑Risks Sana Biotechnology’s SC451 Program and Supports Buy Rating

TIPRANKS
·
Mar 14

BUZZ-Sana Biotechnology rises as cell transplant shows promise in type 1 diabetes treatment

Reuters
·
Mar 13